All Helmholtz Impuls- und Vernetzungsfonds articles
-
NewsInnovative antibiotic shows promise for drug-resistant bacteria
Researchers have demonstrated a potential antibacterial treatment from a modified darobactin, reporting proof-of-concept animal trials on infections caused by bacteria, including E. coli, that are known to develop drug resistance.
